Yifeng Pharmacy Chain (603939) Stock Overview
Engages in the retail business of pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
603939 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Yifeng Pharmacy Chain Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥25.22 |
| 52 Week High | CN¥29.26 |
| 52 Week Low | CN¥17.98 |
| Beta | 0.49 |
| 1 Month Change | 3.91% |
| 3 Month Change | 7.18% |
| 1 Year Change | 35.16% |
| 3 Year Change | -9.68% |
| 5 Year Change | -44.75% |
| Change since IPO | 450.02% |
Recent News & Updates
Recent updates
Market Still Lacking Some Conviction On Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939)
Feb 07
We Think Yifeng Pharmacy Chain (SHSE:603939) Can Stay On Top Of Its Debt
Jan 17Returns On Capital At Yifeng Pharmacy Chain (SHSE:603939) Have Stalled
Dec 12We Like The Quality Of Yifeng Pharmacy Chain's (SHSE:603939) Earnings
Nov 06The Market Lifts Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Shares 28% But It Can Do More
Sep 27Investors Met With Slowing Returns on Capital At Yifeng Pharmacy Chain (SHSE:603939)
Jul 29Slammed 27% Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Screens Well Here But There Might Be A Catch
Jun 20Yifeng Pharmacy Chain (SHSE:603939) Seems To Use Debt Rather Sparingly
May 24Yifeng Pharmacy Chain's (SHSE:603939) Solid Earnings Are Supported By Other Strong Factors
May 06Is Now The Time To Put Yifeng Pharmacy Chain (SHSE:603939) On Your Watchlist?
Apr 13Market Participants Recognise Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Earnings
Mar 28Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Intrinsic Value Is Potentially 100% Above Its Share Price
Mar 13Shareholder Returns
| 603939 | CN Consumer Retailing | CN Market | |
|---|---|---|---|
| 7D | -2.1% | -3.5% | -0.1% |
| 1Y | 35.2% | 78.5% | 54.9% |
Return vs Industry: 603939 underperformed the CN Consumer Retailing industry which returned 80.4% over the past year.
Return vs Market: 603939 underperformed the CN Market which returned 55% over the past year.
Price Volatility
| 603939 volatility | |
|---|---|
| 603939 Average Weekly Movement | 3.6% |
| Consumer Retailing Industry Average Movement | 4.0% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in CN Market | 8.9% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 603939 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603939's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 40,018 | Gao Yi | www.yfdyf.cn |
Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. It offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health.
Yifeng Pharmacy Chain Co., Ltd. Fundamentals Summary
| 603939 fundamental statistics | |
|---|---|
| Market cap | CN¥30.58b |
| Earnings (TTM) | CN¥1.61b |
| Revenue (TTM) | CN¥24.02b |
Is 603939 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603939 income statement (TTM) | |
|---|---|
| Revenue | CN¥24.02b |
| Cost of Revenue | CN¥14.43b |
| Gross Profit | CN¥9.60b |
| Other Expenses | CN¥7.98b |
| Earnings | CN¥1.61b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.33 |
| Gross Margin | 39.94% |
| Net Profit Margin | 6.71% |
| Debt/Equity Ratio | 14.0% |
How did 603939 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/19 16:34 |
| End of Day Share Price | 2025/09/19 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Yifeng Pharmacy Chain Co., Ltd. is covered by 24 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ethan Cui | BofA Global Research |
| Qianyi Li | China International Capital Corporation Limited |
| Bing Zhao | China Renaissance Securities |